High quality Anastrozole

Specifciation:

                             1.Competitive price
                             2.Fast Delivery Within 2 days
                             3.SGS , BV, GMP,ISO approve
                             4.Professional factory

      Product Description

Description of Anastrozole 120511-73-1:

CAS Number:120511-73-1

Name:Anastrozole

Formula:C17H19N5

Molecular Weight:293.37 .

Synonyms:10-Methoxy-5H-dibenz[b,f]azepine-5-carbonylchloride;1,3-Benzenediacetonitrile,a,a,a',a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)- (9CI);2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile);2-[3-(2-Cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile;Asiolex;Anastrol;

Density:1.08 g/cm3

Melting Point:81 - 82 ºC

Boiling Point:469.7 ºC at 760 mmHg

Flash Point:237.9 ºC

Appearance:white crystalline solid

   Certification of Analysis

                          Function&Application

   Anastrozole is a potent selective triazole aromatase inhibitor that inhibits the aromatase that cytochrome P-450 is dependent on to prevent the biosynthesis of estrogen. Estrogen is the main stimulating factor for breast cancer cell growth. This drug’s half maximal inhibitory concentration (IC50) value to human placental aromatase is 15nmol/L. Compared to the traditional drug tamoxifen, Anastrozole can comprehensively and effectively lower the risks of breast cancer recurrence and metastasis, thus extending patients’ disease-free survival.
    Anastrozole is suitable for treating postmenopausal advanced breast cancer patients, especially postmenopausal advanced breast cancer patients who experienced recurrence following hormone assisted therapy.